Skip to main content

ADVERTISEMENT

Edan Stanley

News
04/26/2022
Pharmacists are both accessible and cost-effective providers of vaccinations; however, recent data show administrative factors are thwarting efforts to improve vaccination rates.
Pharmacists are both accessible and cost-effective providers of vaccinations; however, recent data show administrative factors are thwarting efforts to improve vaccination rates.
Pharmacists are both accessible...
04/26/2022
Pharmacy Learning Network
Norm Smith, Principle Payer Market Research Consultant
Podcasts
04/19/2022
Norm Smith, principal payer market research consultant, emphasizes the importance of ensuring market access teams are equipped with quality value propositions which demonstrate the clinical value and cost benefits of overactive bladder...
Norm Smith, principal payer market research consultant, emphasizes the importance of ensuring market access teams are equipped with quality value propositions which demonstrate the clinical value and cost benefits of overactive bladder...
Norm Smith, principal payer...
04/19/2022
First Report Managed Care
News
04/04/2022
An alternative FDA-approved injection therapy option is now available to increase blood pressure in adult patients who remain hypotensive.
An alternative FDA-approved injection therapy option is now available to increase blood pressure in adult patients who remain hypotensive.
An alternative FDA-approved...
04/04/2022
Integrated Healthcare Executive
News
04/01/2022
“These funds will support initial planning and implementation to get the state/territory programs off the ground, which would ensure more people with Medicaid can receive high-quality, cost-effective, person-centered services in a setting...
“These funds will support initial planning and implementation to get the state/territory programs off the ground, which would ensure more people with Medicaid can receive high-quality, cost-effective, person-centered services in a setting...
“These funds will support...
04/01/2022
First Report Managed Care
Conference Coverage
03/31/2022
In a recent session at AMCP 2022, presenters shared updates on current legislative efforts related to pharmacist provider status implementation, including how reimbursing pharmacists could drive improvements in both quality and clinical...
In a recent session at AMCP 2022, presenters shared updates on current legislative efforts related to pharmacist provider status implementation, including how reimbursing pharmacists could drive improvements in both quality and clinical...
In a recent session at AMCP...
03/31/2022
Pharmacy Learning Network
News
03/31/2022
Pharmacist interventions geared toward reducing duplicate or unnecessary prescriptions for people with HIV saved health plans millions of dollars over 5.5 years.
Pharmacist interventions geared toward reducing duplicate or unnecessary prescriptions for people with HIV saved health plans millions of dollars over 5.5 years.
Pharmacist interventions geared...
03/31/2022
First Report Managed Care
Conference Coverage
03/30/2022
In one of the first sessions of AMCP 2022, speakers offered updates on legislation and regulatory changes that could affect formularies and medication management decisions by health plans in the upcoming year.
In one of the first sessions of AMCP 2022, speakers offered updates on legislation and regulatory changes that could affect formularies and medication management decisions by health plans in the upcoming year.
In one of the first sessions of...
03/30/2022
First Report Managed Care
News
03/18/2022
Findings indicate most veterans with depression received at least minimal treatment but few veterans received timely follow-up care afterward.
Findings indicate most veterans with depression received at least minimal treatment but few veterans received timely follow-up care afterward.
Findings indicate most veterans...
03/18/2022
Veterans Health Today
Conference Insider
03/15/2022
According to a recent presentation at the 2022 American Academy of Allergy, Asthma, & Immunology Annual Meeting, replication-incompetent adenovirus and mRNA vaccines against COVID-19 are tolerated among patients with confirmed or suspected...
According to a recent presentation at the 2022 American Academy of Allergy, Asthma, & Immunology Annual Meeting, replication-incompetent adenovirus and mRNA vaccines against COVID-19 are tolerated among patients with confirmed or suspected...
According to a recent...
03/15/2022
First Report Managed Care
News
03/10/2022
A new piece of legislation designed to improve patient access to emerging therapy options by creating a statutory safe harbor for proactive economic and scientific communications between manufacturers and payers prior to FDA approval was...
A new piece of legislation designed to improve patient access to emerging therapy options by creating a statutory safe harbor for proactive economic and scientific communications between manufacturers and payers prior to FDA approval was...
A new piece of legislation...
03/10/2022
First Report Managed Care